Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Pittman

Public Health & General Preventive Medicine Raleigh, NC Medical Doctor

NPI 1164536363 CMS profile 424970

4505 Fair Meadows Ln, Raleigh, NC 27607

Open in the dashboard

General payments

$416

11 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, John Pittman of Raleigh, NC is reported in the CMS Open Payments database as having received $416 across 11 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 74th percentile of Public Health & General Preventive Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $70 1
2021 General $12 1
2020 General $50 2
2019 General $284 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Pittman
  • Public Health & General Preventive Medicine median
  • Middle half of Public Health & General Preventive Medicine
  • National median

In program year 2025, general payments to John Pittman were reported at $70. Among 185 Public Health & General Preventive Medicine profiles paid that year, the median was $99 and the middle half received between $32 and $365.

Show as a table
Year John Pittman Public Health & General Preventive Medicine median Middle half National median
2019 $284 $99 $22–$287 $163
2020 $50 $101 $21–$478 $114
2021 $12 $99 $31–$856 $132
2022 $0 $79 $24–$340 $149
2023 $0 $102 $28–$326 $160
2024 $0 $98 $27–$291 $164
2025 $70 $99 $32–$365 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Romark Laboratories, LC $320 8 payments
  2. 60 Degrees Pharmaceuticals $70 1 payment
  3. CSL Behring $26 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $416 11 payments
Products named General payments · program years 2019–2025
  1. ALINIA Gastroenterology $320 8 payments
  2. ALINIA Gastroenterology $320 8 payments
  3. ALINIA Gastroenterology $320 8 payments
  4. Hizentra $26 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 14 drugs

Part D claims

364

Median for Preventive Medicine: 100

Drug cost

$874,205

Median for Preventive Medicine: $5,055

Branded share of claims

48.1%

Median for Preventive Medicine: 27.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 Brand 41 $470,438
Panzyga Immun Glob G(Igg)-Ifas/Glycine Brand 15 $204,939
Gamunex-C Immune Globul G/Gly/Iga Avg 46 Brand 40 $190,722
Synthroid Levothyroxine Sodium Brand 19 $1,712
Nystatin Generic 23 $1,453
Armour Thyroid Thyroid,pork Brand 21 $1,393
Fluconazole Generic 45 $1,116
Liothyronine Sodium Generic 19 $665
Np Thyroid Thyroid,pork Brand 16 $602
Levothyroxine Sodium Generic 66 $584

The 10 drugs with the highest cost, of 14 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 584 Part D prescribers listed as Preventive Medicine; they describe a distribution and say nothing about conduct.

Records

11 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Public Health & General Preventive Medicine in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record